Stage III Lung Cancer AJCC v8
Showing 26 - 50 of 68
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Japan, United
Recruiting
- Limited Stage Lung Small Cell Carcinoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +544 more
Aug 24, 2022
Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +17 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 19, 2022
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Recruiting
- Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
- +7 more
- Cabozantinib S-malate
- +6 more
-
Birmingham, Alabama
- +592 more
Aug 23, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in
Recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +3 more
-
Indianapolis, Indiana
- +4 more
Aug 19, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Bevacizumab
- Brigatinib
-
Duarte, California
- +4 more
Aug 17, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire
Completed
- Caregiver
- +11 more
- Palliative Therapy
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 11, 2022
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma Trial
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +10 more
- Antineoplastic Immune Cell
- +4 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Aug 12, 2022
Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Orange,
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +8 more
-
Orange, California
- +2 more
Aug 10, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Biopsy
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 2, 2022
Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,
Recruiting
- Advanced Bladder Carcinoma
- +34 more
- Atezolizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Recruiting
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +8 more
- Aurora A Kinase Inhibitor LY3295668
- Osimertinib
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma
Recruiting
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
- +33 more
- Communication Intervention
- +2 more
-
New York, New York
- +3 more
Jun 29, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,
Recruiting
- Lung Non-Small Cell Carcinoma
- +15 more
- Best Practice
- +2 more
-
Portland, Oregon
- +1 more
Jun 8, 2022
Malignant Female Reproductive System Tumor, Stage 0 Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Malignant Female Reproductive System Neoplasm
- +16 more
- Educational Intervention
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Advanced Lung Carcinoma
- +8 more
- Educational Intervention
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 3, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +4 more
- 6 Minute Walk Functional Test
- +6 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2022
Development of Chemotherapy-Induced Peripheral Neuropathy in
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +45 more
- Chemotherapy
- +2 more
-
Antioch, California
- +168 more
May 3, 2022
Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,
Recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Carboplatin
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Seattle
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +4 more
- Cisplatin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 13, 2022